Cargando…

Profiling the Stromal and Vascular Heterogeneity in Patient-derived Xenograft Models of Head and Neck Cancer: Impact on Therapeutic Response

Head and neck squamous cell carcinomas (HNSCC) represent a group of epithelial neoplasms that exhibit considerable heterogeneity in clinical behavior. Here, we examined the stromal and vascular heterogeneity in a panel of patient-derived xenograft (PDX) models of HNSCC and the impact on therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Folaron, Margaret, Merzianu, Mihai, Duvvuri, Umamaheswar, Ferris, Robert L., Seshadri, Mukund
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679003/ https://www.ncbi.nlm.nih.gov/pubmed/31284584 http://dx.doi.org/10.3390/cancers11070951

Ejemplares similares

Preclinical Activity of the Vascular Disrupting Agent OXi4503 against Head and Neck Cancer
por: Bothwell, Katelyn D., et al.
Publicado: (2016)

Multimodal imaging guided preclinical trials of vascular targeting in prostate cancer
por: Kalmuk, James, et al.
Publicado: (2015)

Long-Term Patient-Reported Quality of Life After Stereotactic Body Radiation Therapy for Recurrent, Previously-Irradiated Head and Neck Cancer
por: Thomas, Joel, et al.
Publicado: (2020)

Editorial to the head and neck cancer—series
por: Seshadri, Mukund
Publicado: (2021)

Adrenergic-Angiogenic Crosstalk in Head and Neck Cancer: Mechanisms and Therapeutic Implications
por: Vincent-Chong, Vui King, et al.
Publicado: (2021)

Photoacoustic Imaging as an Early Biomarker of Radio Therapeutic Efficacy in Head and Neck Cancer
por: Rich, Laurie. J., et al.
Publicado: (2018)

Combined magnetic resonance and optical imaging of head and neck tumor xenografts using Gadolinium-labelled phosphorescent polymeric nanomicelles
por: Kumar, Rajiv, et al.
Publicado: (2010)

ANO1/TMEM16A interacts with EGFR and correlates with sensitivity to EGFR-targeting therapy in head and neck cancer
por: Bill, Anke, et al.
Publicado: (2015)

Phase I Study of Ficlatuzumab and Cetuximab in Cetuximab-Resistant, Recurrent/Metastatic Head and Neck Cancer
por: Bauman, Julie E., et al.
Publicado: (2020)

Therapeutic implications of transcriptomics in head and neck cancer patient-derived xenografts
por: Lee, Rex H., et al.
Publicado: (2023)

Xenograft models of head and neck cancers
por: Sano, Daisuke, et al.
Publicado: (2009)

TMEM16A/ANO1 is differentially expressed in HPV-negative versus HPV-positive head and neck squamous cell carcinoma through promoter methylation
por: Dixit, Ronak, et al.
Publicado: (2015)

Definitive local therapy to head and neck squamous cell carcinoma with distant metastasis
por: Borson, Steven, et al.
Publicado: (2022)

DNA methylation regulates TMEM16A/ANO1 expression through multiple CpG islands in head and neck squamous cell carcinoma
por: Finegersh, Andrey, et al.
Publicado: (2017)

Application of Machine Learning Methods to Improve the Performance of Ultrasound in Head and Neck Oncology: A Literature Review
por: DeJohn, Celia R., et al.
Publicado: (2022)

Spatiotemporal Optoacoustic Mapping of Tumor Hemodynamics in a Clinically Relevant Orthotopic Rabbit Model of Head and Neck Cancer()
por: Rich, Laurie J., et al.
Publicado: (2017)

B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma
por: Ruffin, Ayana T., et al.
Publicado: (2021)

Bioactive sphingolipid profile in a xenograft mouse model of head and neck squamous cell carcinoma
por: Bai, Aiping, et al.
Publicado: (2019)

A phase Ⅱ prospective trial of photobiomodulation therapy in limiting oral mucositis in the treatment of locally advanced head and neck cancer patients
por: Taylor, Janielle K.‐A., et al.
Publicado: (2022)

Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing
por: Kürten, Cornelius H. L., et al.
Publicado: (2021)

HER3 targeting potentiates growth suppressive effects of the PI3K inhibitor BYL719 in pre-clinical models of head and neck squamous cell carcinoma
por: Meister, Kara S., et al.
Publicado: (2019)

Molecular Profile of Locally Aggressive Well Differentiated Thyroid Cancers
por: Mady, Leila J., et al.
Publicado: (2020)

Xenograft assessment of predictive biomarkers for standard head and neck cancer therapies
por: Stein, Andrew P, et al.
Publicado: (2015)

Surgeon satisfaction and outcomes of tele-proctoring for robotic gynecologic surgery
por: Artsen, Amanda M., et al.
Publicado: (2021)

Assessing the learning curve associated with a novel flexible robot in the pre-clinical and clinical setting
por: Zhu, Toby S., et al.
Publicado: (2021)

Phase II Trial of CDX-3379 and Cetuximab in Recurrent/Metastatic, HPV-Negative, Cetuximab-Resistant Head and Neck Cancer
por: Bauman, Julie E., et al.
Publicado: (2022)

Metoclopramide enhances the effect of cisplatin on xenografted squamous cell carcinoma of the head and neck.
por: KjellÃ©n, E., et al.
Publicado: (1989)

Chemosensitivity of human head and neck cancer xenografts in the clonogenic assay and in nude mice.
por: Boerrigter, G. H., et al.
Publicado: (1986)

Electrochemotherapy of radioresistant head and neck squamous cell carcinoma cells and tumor xenografts
por: Zakelj, Martina Niksic, et al.
Publicado: (2019)

Establishment and characterization of patient-derived xenografts as paraclinical models for head and neck cancer
por: Kang, Han Na, et al.
Publicado: (2020)

Vascular architecture and hypoxic profiles in human head and neck squamous cell carcinomas
por: Wijffels, K I E M, et al.
Publicado: (2000)

Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for PIK3CA-altered head and neck cancer
por: Hedberg, Matthew L., et al.
Publicado: (2019)

Intratumour heterogeneity in the uptake of macromolecular therapeutic agents in human melanoma xenografts
por: Graff, B A, et al.
Publicado: (2003)

Mesenchymal Stromal Cells: Heterogeneity and Therapeutical Applications
por: Ouzin, Meryem, et al.
Publicado: (2023)

Caveolin-1 and Sox-2 are predictive biomarkers of cetuximab response in head and neck cancer
por: Bouhaddou, Mehdi, et al.
Publicado: (2021)

Otolaryngology, Head and Neck Surgery
por: Yang, Tsung-Lin, et al.
Publicado: (2014)

Immunotherapy for Head and Neck Squamous Cell Carcinoma
por: Moskovitz, Jessica, et al.
Publicado: (2018)

Intraoperative identification of the human communicating nerve during thyroidectomy
por: Hodnett, Benjamin L., et al.
Publicado: (2015)

Influence of Handling Conditions on the Establishment and Propagation of Head and Neck Cancer Patient Derived Xenografts
por: Stein, Andrew P., et al.
Publicado: (2014)

Xenografts derived from patients with head and neck cancer recapitulate patient tumour properties
por: Makita, Haruna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pekq9kgd1lv0rh28h0r0bpsi18